title: Augmentation of T-cell response with a melanoma cell vaccine expressing specific HLA-A antigens.
authors.affiliation: John Wayne Cancer Institute, Santa Monica, California 90404.
authors.forename: D S
authors.initials: DS
authors.lastname: Hoon
authors.forename: T
authors.initials: T
authors.lastname: Morisaki
authors.forename: A
authors.initials: A
authors.lastname: Uchiyama
authors.forename: Y
authors.initials: Y
authors.lastname: Hayashi
authors.forename: L J
authors.initials: LJ
authors.lastname: Foshag
authors.forename: A J
authors.initials: AJ
authors.lastname: Nizze
authors.forename: D L
authors.initials: DL
authors.lastname: Morton
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology; D015234:HLA-A Antigens / Q000276:immunology*; D006648:Histocompatibility; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins / Q000276:immunology; D010865:Pilot Projects; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
chemical_list: D000951:Antigens, Neoplasm; D015234:HLA-A Antigens; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins